Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial

Efficacy and safety of Saccharomyces boulardii as adjunct therapy with Vancomycin in treating Clostridioides difficile infection: A randomized controlled trial

Abstract Clostridioides difficile infection (CDI) is a significant cause of hospital-acquired diarrhea, leading to high morbidity, recurrence, and healthcare costs. Probiotics like Saccharomyces boulardii show potential as an adjunct therapy to standard CDI treatment, but further trials are needed t...

Full description

Saved in:
Bibliographic Details
Main Authors: Taned Chitapanarux, Umaporn Wiracha, Poramed Winichakoon, Parichat Salee, Patrinee Traisathit
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Clinical cure
Clostridioides difficile infection
Recurrence rates
Saccharomyces boulardii
Vancomycin
Online Access:https://doi.org/10.1038/s41598-025-04986-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-04986-2

Similar Items